Reuters logo
BRIEF-Halozyme reports first quarter 2017 financial results
May 9, 2017 / 8:29 PM / 4 months ago

BRIEF-Halozyme reports first quarter 2017 financial results

May 9 (Reuters) - Halozyme Therapeutics Inc:

* Halozyme reports first quarter 2017 financial results

* Q1 loss per share $0.26

* Q1 revenue $29.6 million versus I/B/E/S view $30.9 million

* Q1 earnings per share view $-0.25 -- Thomson Reuters I/B/E/S

* Sees FY 2017 revenue $115 million to $130 million

* Says for 2017, company reiterated its financial guidance of net revenue of $115 million to $130 million

* FY2017 revenue view $132.6 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below